There are ongoing investigations into the treatment of conditions associated with Central Nervous System under effect from this compound
Week 1: Less Drag, More Momentum By the end of the first week, many people report feeling more functional day to day
J Pharmacol Sci 95:1926 Prkacin I, Separovic J, Aralicia G, Perovic D, Gjurasin M, Lovric-Bencic M, Stancic-Rokotov D, Staresinic M, Anic T, Mikus D et al (2001) Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol, but not ranitidine
The Research Gap Phase I safety trials have been conducted but results were never published despite completed status
Its important to follow these to get the best results